This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Mar 15;154(6):JC3-13.

doi: 10.7326/0003-4819-154-6-201103150-02013.

ACP Journal Club. Anti-tumor necrosis factor therapy was not associated with greater risk for mortality than standard therapy in rheumatoid arthritis

Ami Schattner¹

Affiliations

PMID: 21403064
DOI: 10.7326/0003-4819-154-6-201103150-02013

Comment

ACP Journal Club. Anti-tumor necrosis factor therapy was not associated with greater risk for mortality than standard therapy in rheumatoid arthritis

Ami Schattner. Ann Intern Med. 2011.

. 2011 Mar 15;154(6):JC3-13.

doi: 10.7326/0003-4819-154-6-201103150-02013.

Author

Ami Schattner¹

Affiliation

¹ Hebrew University Hadassah, Jerusalem, Israel.

PMID: 21403064
DOI: 10.7326/0003-4819-154-6-201103150-02013

No abstract available

PubMed Disclaimer

Comment on

No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Lunt M, Watson KD, Dixon WG; British Society for Rheumatology Biologics Register Control Centre Consortium; Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register. Lunt M, et al. Arthritis Rheum. 2010 Nov;62(11):3145-53. doi: 10.1002/art.27660. Arthritis Rheum. 2010. PMID: 20662063 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon